Lyell Immunopharma logo

Lyell Immunopharma Share Price (NASDAQ: LYEL)

$11.13

0.03

(0.27%)

Last updated on

Check the interactive Lyell Immunopharma Stock chart to analyse performance

Lyell Immunopharma, Inc Key Stats

Check Lyell Immunopharma key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$11.1
Open
$11.5
Market Capitalization
$213.2M
Today's Volume
$12.4K
Revenue TTM
$60.0K
EBITDA
$-194.9M
Earnings Per Share (EPS)
$-24.26
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-76.59%

Stock Returns calculator for Lyell Immunopharma Stock including INR - Dollar returns

The Lyell Immunopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Lyell Immunopharma investment value today

Current value as on today

₹45,034

Returns

₹54,966

(-54.97%)

Returns from Lyell Immunopharma Stock

₹60,250 (-60.25%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Lyell Immunopharma Stock

0%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Lyell Immunopharma Stock from India on INDmoney has increased by 0% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Lyell Immunopharma, Inc

  • Name

    Holdings %

  • MWG Management Ltd.

    5.25%

  • Foresite Capital Management IV, LLC

    4.17%

  • Orland Properties Ltd

    3.93%

  • BlackRock Inc

    3.31%

  • Decheng Capital LLC

    3.10%

  • venBio Partners LLC

    2.46%

Analyst Recommendation on Lyell Immunopharma Stock

Rating
Trend

Buy

    70%Buy

    30%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Lyell Immunopharma(by analysts ranked 0 to 5 stars)

Lyell Immunopharma Share Price Target

What analysts predicted

Downside of 1.17%

Target:

$11.00

Current:

$11.13

Lyell Immunopharma share price target is $11.00, a slight Downside of 1.17% compared to current price of $11.13 as per analysts' prediction.

Lyell Immunopharma Stock Insights

  • Price Movement

    In the last 1 year, LYEL stock has moved down by -61.7%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 7.0K → 8.0K (in $), with an average increase of 12.5% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -191.93M → -42.68M (in $), with an average increase of 145.0% per quarter
  • LYEL vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 131.6%
  • LYEL vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 203.8%
  • Price to Sales

    ForLYEL every $1 of sales, investors are willing to pay $2752.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Lyell Immunopharma, Inc Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$61.0K
↓ 53.08%
Net Income
$-343.0M
↑ 46.18%
Net Profit Margin
-562.3K%
↓ 381799.1%

Lyell Immunopharma Technicals Summary

Sell

Neutral

Buy

Lyell Immunopharma is currently in a neutral trading position according to technical analysis indicators.

Lyell Immunopharma, Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Lyell Immunopharma, Inc logo
0.73%
-16.09%
-60.36%
-92.25%
-96.71%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Lyell Immunopharma, Inc

Lyell Immunopharma, Inc., a clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The company develops therapies using various approaches, such as c-Jun overexpression and NR4A3 gene knockout, to endow functional resistance to exhaustion; Epi-R to generate population of stem-like T cells with reduced exhaustion and improved proliferation and antitumor activity; CD62L positive enrichment to generate CAR T cells with enhanced antitumor activity; and Stim-R, a proprietary synthetic-cell mimetic. It is also developing IMPT-314, a dual-targeting CD19/CD20 CAR T-cell product candidate that is in Phase 1/2 clinical development for the treatment of patients with aggressive relapsed/refractory large B-cell non-Hodgkin lymphoma; and solid tumors program which is in preclinical trial targeting solid tumor indications. Lyell Immunopharma, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.
Organization
Lyell Immunopharma
Employees
300
CEO
Dr. Lynn Seely M.D., Ph.D.
Industry
Services

Key Management of Lyell Immunopharma, Inc

NameTitle
Dr. Richard D. Klausner M.D.
Founder & Executive Chairman
Dr. Lynn Seely M.D., Ph.D.
President, CEO & Director
Mr. Stephen J. Hill
Chief Operating Officer
Mr. Matthew Lang J.D.
Advisor
Prof. Stanley R. Riddell M.D.
Founder & Scientific Advisor
Dr. Crystal L. Mackall M.D.
Founder & Scientific Advisor
Mr. Charles W. Newton
Chief Financial Officer
Nellie Dillery
Director of Accounting
Dr. Gary Lee Ph.D.
Chief Scientific Officer
Ms. Ellen Rose
Senior Vice President of Communications & Investor Relations

Important FAQs about investing in LYEL Stock from India :

What is Lyell Immunopharma share price today?

Lyell Immunopharma share price today is $11.13 as on at the close of the market. Lyell Immunopharma share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Lyell Immunopharma share?

Lyell Immunopharma share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Lyell Immunopharma stock price today i.e. is closed at $11.13, lower by 65.22% versus the 52 week high.

How to invest in Lyell Immunopharma Stock (LYEL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Lyell Immunopharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lyell Immunopharma Shares that will get you 0.1348 shares as per Lyell Immunopharma share price of $11.13 per share as on August 30, 2025 at 1:28 am IST.

What is the minimum amount required to buy Lyell Immunopharma Stock (LYEL) from India?

Indian investors can start investing in Lyell Immunopharma (LYEL) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Lyell Immunopharma stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Lyell Immunopharma share’s latest price of $11.13 as on August 30, 2025 at 1:28 am IST, you will get 0.8985 shares of Lyell Immunopharma. Learn more about fractional shares .

What are the returns that Lyell Immunopharma has given to Indian investors in the last 5 years?

Lyell Immunopharma stock has given -96.71% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?